Several April releases seem to signal some basis for optimism for stakeholders in Medicare Advantage and Part D, though with sufficient undertones to recommend caution. Of particular note, the CY 2026 ...
The current state of the Medicare Part D market is a mixed bag, with premiums declining but many payers scaling back options, according to a new analysis from KFF. The report noted that the Centers ...
The national average bid amount for Part D plans will increase from $64.28 in 2024 to $179.45 in 2025, according to information released Monday by the Centers for Medicare and Medicaid Services. The ...
Medicare enrollees who buy the optional Part D drug benefit may see substantial premium price hikes — potentially up to $50 a month — when they shop for next year’s coverage. Such drug plans are used ...
The Inflation Reduction of Act of 2022 included improvements to Medicare Part D, and some have already been enacted—$35 insulin, no more member cost share in the catastrophic phase of coverage, and ...
EnforceMintz — Medicare Advantage and Part D Programs to Remain in the Enforcement Spotlight in 2025
As government scrutiny and enforcement targeting the Medicare Advantage (Medicare Part C) program continued in 2024, the industry’s response to agency actions escalated. Last year also resulted in the ...
The Demonstration of Premium Stabilization for Medicare Part D, initiated by the Centers for Medicare and Medicaid Services (CMS) in 2025, was designed to test policy changes that could stabilize ...
Forbes contributors publish independent expert analyses and insights. Bob Carlson researches all facets of retirement finances. The final numbers aren’t in yet, but it looks like premiums for Medicare ...
Medicare enrollees who buy the optional Part D drug benefit may see substantial premium price hikes — potentially up to $50 a month — when they shop for next year’s coverage. Such drug plans are used ...
Fewer choices may be on the menu again as Medicare patients shop for prescription coverage this fall. The number of available, stand-alone drug plans has fallen for a few years, and that trend will ...
Anthem plans get good ratings for members’ happiness and helping with medication management, but they’re priced high and not available in most states. Many, or all, of the products featured on this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results